ECONOMIC OUTCOMES OF CO-TREATMENT OF INSOMNIA AND MAJOR DEPRESSIVE DISORDER (MDD) WITH ESZOPICLONE AND FLUOXETINE VERSUS FLUOXETINE TREATMENT ALONE

被引：0
|
作者：
Snedecor, S. J. [1 ]
Botteman, M. F. [1 ]
Schaefer, K. [2 ]
Sarocco, P. [2 ]
Barry, N. [2 ]
Pickard, A. S. [3 ]
机构：
[1] Pharmerit N Amer LLC, Bethesda, MD USA
[2] Sepracor Inc, Marlborough, MA USA
[3] Univ Illinois, Coll Pharm, Chicago, IL USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66922-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A586 / A586
页数：1
相关论文
共 50 条
  • [1] Eszopiclone co-administered with fluoxetine for insomnia associated with major depressive disorder (MDD): Sleep effects
    Buysse, D
    McCall, V
    Roach, J
    Wessel, T
    Wilson, P
    Caron, J
    Roth, T
    [J]. SLEEP, 2005, 28 : A310 - A311
  • [2] Eszopiclone co-administered with fluoxetine for insomnia associated with major depressive disorder (MDD): Effects following eszopiclone discontinuation
    Krystal, A
    Rubens, R
    Fava, M
    McCall, V
    Wessel, T
    Amato, D
    Caron, J
    Roth, T
    [J]. SLEEP, 2005, 28 : A311 - A311
  • [3] Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): Analysis by severity of insomnia
    McCall, V
    Krystal, A.
    Fava, M.
    Rubens, R.
    Schaefer, K.
    Huang, H.
    Amato, D.
    Roth, T.
    [J]. SLEEP, 2006, 29 : A249 - A249
  • [4] Eszopiclone co-administered with fluoxetine for insomnia associated with major depressive disorder (MDD): An analysis of the effects on depression
    McCall, V
    Fava, M
    Wessell, T
    Rubens, R
    Caron, J
    Amato, D
    Roth, T
    [J]. SLEEP, 2005, 28 : A310 - A310
  • [5] Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): a subgroup analysis
    Roth, T.
    Mccall, W.
    Wessel, T.
    Amato, D.
    Paska, W.
    Fava, M.
    [J]. JOURNAL OF SLEEP RESEARCH, 2008, 17 : 191 - 192
  • [6] Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): A subgroup analysis
    Fava, M.
    McCall, W. V.
    Wessel, T.
    Amato, D.
    Paska, W.
    Montgomery, S.
    Roth, T.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 306 - 306
  • [7] Economic Outcomes of Eszopiclone Treatment in Insomnia and Comorbid Major Depressive Disorder
    Snedecor, Sonya J.
    Botteman, Marc F.
    Schaefer, Kendyl
    Sarocco, Phillip
    Barry, Nadine
    Pickard, A. Simon
    [J]. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2010, 13 (01): : 27 - 35
  • [8] Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder
    Fava, M
    McCall, WV
    Krystal, A
    Wessel, T
    Rubens, R
    Caron, J
    Amato, D
    Roth, T
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (11) : 1052 - 1060
  • [9] Adjunctive eszopiclone and fluoxetine in major depressive disorder and insomnia: Effects on sleep and depression
    Corrigan, M
    McCall, WV
    Fava, M
    Rubens, R
    Wessel, T
    Caron, J
    Amato, D
    Roth, T
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S104 - S105
  • [10] Adjunctive eszopiclone and fluoxetine in major depressive disorder and insomnia: Effects on sleep and depression
    Bowler, K
    Rubens, R
    Wessel, T
    Caron, J
    Amato, D
    McCall, WV
    Fava, M
    Roth, T
    [J]. NEUROLOGY, 2006, 66 (05) : A78 - A78
12345